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Introduction
Livedoid vasculitis is a rare disease that has the clinically char-
acteristic symptoms of purpuric macules and papules of the low-
er legs and feet. These purplish lesions develop into irregularly 
shaped ulcers that ultimately heal into stellate white scars or at-
rophie blanche. It is most common in young to middle-aged wom-
en, and the course seems to be chronic with seasonal exacer-
bations.
1 Because of these characteristic findings it has many 
other synonyms, such as segmental hyalinizing vasculitis, atro-
phie blanche, livedo reticulitis with summer/winter ulceration, 
hypersensitivity-type vasculitis, and painful purpuric ulcers with 
reticular pattern of the lower extremities.
2 Although the typical 
dermatological findings and pathogenesis of this condition have 
been emphasized previously, the involvement of peripheral neu-
ropathy with this dermatological vasculopathy is very rare.
3-5
Case Report
A 48-year-old woman presented with a 2-year history of tin-
gling sensation and numbness of her right fingers. Two years 
prior to her hospital visit, she began to notice that her right ring 
finger and little finger were numb and tingling; 7 months later, 
bruises suddenly appeared on her whole body, and these per-
sisted only on both legs. These multiple purpuric patches devel-
oped into painful ulcerated wounds located mostly on the left 
lateral malleolar areas. The ulcers healed within 2 months, leav-
ing atrophic scars. More and more similar skin lesions devel-
oped on both lower extremities, exhibiting a waxing and wan-
ing course. During this time, the patient also complained of num-
bness and a tingling sensation on the dorsum of both feet, which 
was more severe on the right.
The patient’s family and social history were unremarkable. 
Her previous medical history included a diagnosis of multiple 
cysts in the kidney and pancreas. She had also undergone a dis-
tal pancreatectomy; the removed tissue had pathologically con-
firmed serous oligocystic adenoma. There was no drug history, 
including use of an oral contraceptive pill.
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When initially evaluated in our hospital, her cranial nerve 
function, motor function including muscle bulk, tone, power 
and deep-tendon reflex, cerebellar function test, and gait were 
all normal. However, a sensory examination revealed about a 
50% hypesthesia for touch and pinprick sensation on the dor-
sum of both feet, the right fourth and fifth fingers, and the me-
dial palm, which is innervated by the ulnar nerve. Multiple ir-
regularly shaped ulcerative skin lesions and eschar with some 
healed ivory-white colored atrophic scars were seen in the left 
lateral malleolar area (Fig. 1). The results of the following lab-
oratory studies regarding autoimmune disease and coagulation 
defects were normal, negative, or nonspecific: complete blood 
count, routine blood chemistry with blood glucose, urinalysis, 
serological test for syphilis, human immunodeficiency virus, and 
hepatitis B, sedimentation rate, antinuclear antibody, anti-dou-
ble-stranded DNA antibodies, antineutrophilic cytoplasmic an-
tibodies, antiphospholipid antibody, anticardiolipin antibody, an-
ti-Sjögren’s syndrome (SS)A/SSB antibody, protein C, protein 
S, cryoglobulin, rheumatoid factor, thyroid function test, vita-
min B12, folate, creatine kinase, platelet aggregation panel, an-
tithrombin III activity, gene study of factor V Leiden mutation, 
and prothrombin 20210 G>A. A cerebrospinal-fluid examina-
tion and Doppler ultrasound of both lower extremities produced 
normal results. The initial nerve conduction study (Table 1) re-
vealed a diminished right ulnar sensory nerve action potential, 
and both sural sensory nerve action potentials were absent, even 
with repetitive stimulation. The amplitudes of the compound mo-
tor nerve action potentials of both the peroneal and posterior 
tibial nerves were decreased. Other motor and sensory conduc-
tion results were normal. A electrophysiological study revealed 
no abnormal temporal dispersion or partial conduction block.
Skin-punch biopsy sampling was conducted on the left lat-
eral ankle. The findings were consistent with livedoid vascu-
lopathy with fibrin deposition within the vessel walls, and throm-
bi and scattered perivascular lymphocytic inflammation.
A nerve biopsy sample was removed from the right sural 
nerve, which revealed endoneurial capillary ectasia and con-
gestion with hemorrhage, with extensive infarct of the periph-
eral nerve and Schwann cells. Occasional perivascular lympho-
cytes were observed infiltrating the arterioles in the epineurium. 
A marked degeneration of axons and the myelin sheath were 
observed, and the Schwann cell cytoplasm contained many au-
tophagic vacuoles and myelin figures (Fig. 2). There was no def-
inite evidence of vasculitis in the form of vessel necrosis and leu-
kocytoclasia. The biopsy findings were suggestive of ischemic 
peripheral neuropathy.
This patient was diagnosed with ischemic neuropathy asso-
ciated with livedoid vasculitis and treated with the antithrom-
botic and antifibrinolytic agents pentoxifylline and clopidogrel, 
respectively. The patient suffered no further attacks during the 
subsequent 3-year follow-up period.
Discussion
While the name livedoid vasculitis is generally used, histopath-
ological studies have shown that this condition can be more ac-
curately described as livedoid vasculopathy. Typical histopath-
ological findings of livedoid vasculitis are fibrin deposition 
within the affected walls of blood vessels and thrombus forma-
tion within the lumen. The extent of any inflammation is very 
limited.
6,7 These findings were consistent with our patient’s skin 
and nerve biopsy findings, showing ischemic neuropathy more 
than vasculitic neuropathy.
Livedoid vasculitis has been described as a sole entity or in 
association with other diseases, such as primary systemic lupus 
erythematosus, antiphospholipid antibody syndrome,
8,9 and oth-
er conditions associated with abnormalities of the coagulation 
system (e.g., protein C deficiency,
10 abnormalities of the tissue 
plasminogen activator system,
11 antithrombin III deficiency,
12 
elevated homocysteine levels,
13 and factor V Leiden mutations).
14 
Although the pathogenesis of livedoid vasculitis between vaso-
occlusive and vasculitis continues to be debated, these patho-
logic and etiological studies lean toward the vaso-occlusive mech-
anism as a primary pathogenesis.
15
The sequential nature of the numbness and tingling sensation 
in the patient’s right hand and both feet is a classic feature of 
mononeuropathy multiplex. This is supported by her electrophys-
iological findings. Many systemic diseases can be related to 
mononeuropathy multiplex, such as vasculitis, connective 
tissue disease, cryobulinemia, sarcoidosis, diabetes, amyloido-
B  
Fig. 1. Multiple painful ulcerations with healed white scarring in the 
bilateral lateral malleolar area. A: left lateral malleolar area. B: right 
lateral malleolar area.
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sis, neoplasm, and infections. The patient exhibited mononeu-
ropathy multiplex with characteristic skin lesions, and so we 
could limit the disease entity to connective tissue diseases such 
as systemic lupus erythematosus, SS, and antiphospholipid an-
tibody syndrome, and vasculitis conditions such as polyarteri-
tis nodosa, infectious diseases such as leprosy or syphilis, and 
livedo vasculopathy. However, our laboratory results did not 
support the presence of any connective tissue diseases or vas-
culitis. Furthermore, the skin lesions that formed petechiae - 
which comprised recurrent, irregularly shaped, hyperpigment-
ed ulcers and atrophie blanche - also differed from the derma-
tological findings of both leprosy and syphilis. Leprosy is usually 
associated with more hypopigmented and well-defined lesions, 
with occasional plaque and tuberculoid-like changes.
16 Syphi-
Fig. 2. Histopathology findings of a su-
ral nerve biopsy. A: Extensive infarct of 
the peripheral nerve and Schwann cells 
(hematoxylin-eosin stain, original mag-
nification ×40). B: Endoneurial capillary 
ectasia and congestion with hemor-
rhage (hematoxylin-eosin stain, origi-
nal magnification ×200). C: Intravascu-
lar thrombosis with mild lymphocytic 
infiltration present in the epineurium. 
There was no definite neutrophilia or 
leukocytoclasia, suggesting vasculitis (i: 
hematoxylin-eosin stain, ii: leukocyte com-
mon antigen stain, original magnification 
×200). D: Electron micrograph showing 
marked degeneration of axons and 
their myelin sheath, with the Schwann 
cell cytoplasm containing many autopha-
gic vacuoles and myelin figures.
Table 1. Results of the initial nerve conduction study
Motor nerve conduction studies Sensory nerve conduction study
Motor nerve Segment Latency (ms) Amplitude (mV)  NCV (m/s) Sensory nerve Segment Amplitude (µV) NCV (m/s)
Median motor  TL 3.1 (<3.6) 14.8 (>5) Median sensory F-W 39.8 (>10) 46 (>41.26)
  (right) W-E 14.7 (>5) 55 (>49.96)   (right) W-E 41.6 (>10) 57 (>49.39)
E-AX 14.6 (>5) 71 (>55.96)    E-AX 44.7 (>10) 59 (>53.95)
F-wave 25.6 (<28.48)         
Ulnar motor  TL 2.5 (<2.51) 9.8 (>5) Ulnar sensory  F-W 2.6 (>10) 52 (>39.26)
  (left) W-BE 9.6 (>5) 55 (>50.61)   (right) W-E 4.8 (>10) 56 (>47.46)
BE-AE 9.4 (>5) 59 (>52.69) E-AX 8.7 (>10) 56 (>48.18)
AE-AX 8.8 (>5) 58 (>58.22)  
F-wave 26.4 (<28.64)
Tibial  TL 3.5/UC (<5.11) 5.5/UC (>5) Sural  MC-A NP/NP (>6)
  (right/left) K-A 4.2/2.7 (>5) 48/UC (>40.63)   (right/left)
F-wave 44.7/NP 
(<51.75)
H-reflex NP/NP (<30.2)
Peroneal  TL 4.7/4.7 (<4.78) 1.1/0.6 (>4)
  (right/left) K-A 0.9/0.6 (>4) 48/47 (>41.85)
K-PF 0.8/0.6 (>4) 44/50 (>39.11)
F-wave NP/NP (<47.52)
NCV: Nerve conduction velocity, TL: terminal latency, W: wrist, E: elbow, AX: axilla, BE: below elbow, AE: above elbow, PF: popliteal fossa, 
A: ankle, F: finger, P: palm, MC: middle calf, NP: No potential evoked, UC: uncheckable due to ulcer around the malleolous.Ischemic Neuropathy and Livedoid Vasculitis
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lis characteristically presents hard, slightly elevated, round ul-
cers in the mouth and genital area known as chancres, and the 
subsequent formation of gummata.
17 With the aid of an exclu-
sive diagnostic process and examination of histopathological 
findings, we concluded that the patient was suffering from live-
doid vasculopathy, and more specifically, livedoid vasculitis. Her 
mononeuropathy multiplex can be explained by multifocal ax-
onal damage from thrombotic obstruction of the vasa nervorum 
and the consequent ischemia.
There is no consensus for the treatment of livedoid vasculi-
tis. However, given its potential pathogenesis of coagulation 
abnormality and ischemia phenomenon, many antithrombotic 
and antifibrinolytic agents have been routinely used, including 
heparin,
18 tissue plasminogen activator,
19 pentoxifylline, aspirin, 
and dipyridamole,
20 with long-term anticoagulation,
21 danazol,
22 
ketanserin,
23 beraprost,
12 and prostacyclin.
24 Other immunomodu-
lating therapies such as steroids and immunoglobulins have also 
been applied, but it has been shown that they do not provide long-
term benefits.
25
We report herein a patient who experienced livedoid vascu-
litis combined with a rare neurological disease, mononeuropa-
thy multiplex, which was proven to be ischemic neuropathy by 
nerve biopsy. These phenomena are thought to be attributable to 
a coagulation abnormality, which is also the main pathological 
cause in livedoid vasculitis. Other causes of coagulation defects 
were not revealed in this case. To the best of our knowledge, this 
is one of only very few reports of ischemic neuropathy associated 
with livedoid vasculitis, and has provided valuable insights into 
the disease pathomechanism. Our pathologic findings and other 
laboratory findings were all negative for systemic vasculitis, thus 
supporting the vaso-occlusive mechanism of livedoid vasculitis.
Conflicts of Interest
The authors have no financial conflicts of interest.
Acknowledgements
This work was supported by Grant No.0420100210 from the Seoul Nation-
al University Hospital Research Fund.
REFERENCES
1. Bard JW, Winkelmann RK. Livedo vasculitis. Segmental hyalinizing 
vasculitis of the dermis. Arch Dermatol 1967;96:489-499.
2. Papi M, Diodona B, De Pità O, Silvestri L, Ferranti G, Gantcheva M, 
et al. PURPLE (atrophie blanche): clinical, histological and immunologi-
cal study of twelve patients. J Eur Acad Dermatol Venereol 1997;9: 
129-133.
3. Winkelmann RK, Schroeter AL, Kierland RR, Ryan TM. Clinical 
studies of livedoid vasculitis: (segmental hyalinizing vasculitis). Mayo 
Clin Proc 1974;49:746-750.
4. Toth C, Trotter M, Clark A, Zochodne D. Mononeuropathy multiplex 
in association with livedoid vasculitis. Muscle Nerve 2003;28:634-639.
5. Osada S, Kimura Y, Kawana S. Case of livedoid vasculopathy with 
peripheral neuropathy successfully treated with low-dose warfarin. J 
Dermatol 2010;37:98-101.
6. Gibson LE, Su WP. Cutaneous vasculitis. Rheum Dis Clin North Am 
1995;21:1097-1113.
7. Milstone LM, Braverman IM, Lucky P, Fleckman P. Classification and 
therapy of atrophie blanche. Arch Dermatol 1983;119:963-969.
8. Grattan CE, Burton JL, Boon AP. Sneddon’s syndrome (livedo reticularis 
and cerebral thrombosis) with livedo vasculitis and anticardiolipin 
antibodies. Br J Dermatol 1989;120:441-447.
9. Grob JJ, Bonerandi JJ. Thrombotic skin disease as a marker of the 
anticardiolipin syndrome. Livedo vasculitis and distal gangrene associat-
ed with abnormal serum antiphospholipid activity. J Am Acad Dermatol 
1989;20:1063-1069.
10. Baccard M, Vignon-Pennamen MD, Janier M, Scrobohaci ML, Dubertret 
L. Livedo vasculitis with protein C system deficiency. Arch Dermatol 
1992;128:1410-1411.
11. Pizzo SV, Murray JC, Gonias SL. Atrophie blanche. A disorder associated 
with defective release of tissue plasminogen activator. Arch Pathol Lab 
Med 1986;110:517-519.
12. Tsutsui K, Shirasaki F, Takata M, Takehara K. Successful treatment of 
livedo vasculitis with beraprost sodium: a possible mechanism of throm-
bomodulin upregulation. Dermatology 1996;192:120-124.
13. Gibson GE, Li H, Pittelkow MR. Homocysteinemia and livedoid 
vasculitis. J Am Acad Dermatol 1999;40:279-281.
14. Calamia KT, Balabanova M, Perniciaro C, Walsh JS. Livedo (livedoid) 
vasculitis and the factor V Leiden mutation: additional evidence for 
abnormal coagulation. J Am Acad Dermatol 2002;46:133-137.
15. Khenifer S, Thomas L, Balme B, Dalle S. Livedoid vasculopathy: 
thrombotic or inflammatory disease? Clin Exp Dermatol 2010;35:693-
698.
16. Jacobson RR, Krahenbuhl JL. Leprosy. Lancet 1999;353:655-660.
17. Ooi C, Dayan L. Syphilis. Diagnosis and management in general 
practice. Aust Fam Physician 2002;31:629-635.
18. Jetton RL, Lazarus GS. Minidose heparin therapy for vasculitis of 
atrophie blanche. J Am Acad Dermatol 1983;8:23-26.
19. Klein KL, Pittelkow MR. Tissue plasminogen activator for treatment 
of livedoid vasculitis. Mayo Clin Proc 1992;67:923-933.
20. Drucker CR, Duncan WC. Antiplatelet therapy in atrophie blanche and 
livedo vasculitis. J Am Acad Dermatol 1982;7:359-363.
21. Dedichen J, Gjessing HC. Livedo reticularis with summer ulcerations; 
report of case treated with long-term anticoagulation therapy. Acta Med 
Scand Suppl 1956;319:74-78.
22. Hsiao GH, Chiu HC. Livedoid vasculitis. Response to low-dose danazol. 
Arch Dermatol 1996;132:749-751.
23. Rustin MH, Bunker CB, Dowd PM. Chronic leg ulceration with livedoid 
vasculitis, and response to oral ketanserin. Br J Dermatol 1989;120: 
101-105.
24. Hoogenberg K, Tupker RA, van Essen LH, Smit AJ, Kallenberg CG. 
Successful treatment of ulcerating livedo reticularis with infusions of 
prostacyclin. Br J Dermatol 1992;127:64-66.
25. Amital H, Levy Y, Shoenfeld Y. Use of intravenous immunoglobulin 
in livedo vasculitis. Clin Exp Rheumatol 2000;18:404-406.